Remarkably, the results indicated decreased expression of Nrf2, CAT, SOD1, and SOD2 (P-value <0.02) (Fig. 5A–D) as well as GP91PHOX (P-value <0.02) (Fig. 5D) in COVID-19 patients compared to controls. Here, NFE2L2 is linked to COVID-19.